Securing our Nation’s Pharmaceuticals through
U.S. Manufacturing

Discover Who We Are
Watch The Video

THE PROBLEM

The United States’ drug supply chain is broken, becoming dangerously dependent upon Foreign Suppliers for our most essential generic medicines.

More than 80% of active pharmaceutical ingredients are produced overseas

The manufacturing of generic drugs in the US is vulnerable to disruptions in foreign drug supply chains—this has been made more pressing by recent trade wars and the COVID-19 pandemic.

The US is Facing Drug Shortages

In 2018, the American Medical Association announced that drug shortages now pose an urgent public health crisis in the United States

The US is Dependent on China for its Medication

“[China] wants to disrupt, to dominate and displace American and other Western companies”

Rosemary Gibson
Author of ‘China Rx’


OUR SOLUTION

A public benefit corporation dedicated to manufacturing and securing our nation’s most essential generic medicines, 100% in the U.S.

Phlow corporation is bringing together industry leaders and cutting edge manufacturing

We are a team of experienced pharmaceutical executives dedicated to research, development, and manufacturing, using the latest innovations in advanced manufacturing technology.

Learn More About What We Do

BOARD OF DIRECTORS

Eric Edwards, MD PhD.

Co-Founder & CEO

Learn More

Dr. Frank Gupton, PhD.

Co-Founder & CEO, Medicines for All

Learn More

Martin Van Trieste

President & CEO, Civica Rx

Learn More

Marshall L. Summar, MD

Strategic Advisor and Member of the Board

Learn More

Rosemary Gibson

Strategic Advisor and Member of the Board

Learn More


OUR VISION

Make the U.S. a country where every human being has access to the essential medicines necessary to sustain life and conquer disease


OUR MISSION

To provide high-quality, low-cost generic pharmaceuticals and their ingredients through state-of-the-art, U.S.-based, advanced manufacturing

Learn More About Phlow

Contact us